Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment, » Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read More
Market Commentary: Buffett’s Japanese Play Is Genius
There is a reason Buffett is regarded as the greatest investor of all time. He’s got all sorts of tricks up his sleeve that most investors know nothing about. From warrants to riskless arbitrage, the gamut of innovative strategies he employs is as creative as it is extensive.
But his latest play might be among his most imaginative and intelligent yet.
» Read more about: Market Commentary: Buffett’s Japanese Play Is Genius »
Read MoreMarket Commentary: How To Make Money When You Missed The Move
On June 6, shares of Coinbase plummeted by 16% when it fell on news that the SEC was suing the company for exchange and staking programs. It’s a common enough occurrence to wake up and see a stock plunge, and most investors fall into two buckets by either chasing the move or…
Read More
Market Commentary: Don’t Buy The AI Hype
Artificial intelligence was poorly understood for so long. What some claimed was AI was really human-programmed algorithms, or rulesets with decision-making programmed by a person.
Artificial intelligence is different.
Read More
1 Rare Stock Buffett Is Buying
Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).
These purchases brought Berkshire Hathaway’s holdings in Verisign to 13.2 million shares,
» Read more about: 1 Rare Stock Buffett Is Buying »
Read MoreThe Ivy
Nvidia’s Drop Might Be Your Once-in-a-Decade Opportunity
When markets panic, great companies go on sale and that’s exactly what’s happening with Nvidia right now.
Amid escalating tariff skirmishes and a broader tech pullback, the world’s most important AI company has seen its stock fall nearly 19.9% from its 2025 highs. But don’t let the noise distract you.
Beneath the surface,
» Read more about: Nvidia’s Drop Might Be Your Once-in-a-Decade Opportunity »
Read MoreThe Spotlight
Is Apple’s Dip The Perfect Buying Opportunity?
Apple has fallen by almost 15% from nearly $200 per share in recent months. The decline appeared to precede the major market averages more recent correction but does it bode ominously for Apple or has the recent pullback offered new buyers an opportunity to get in on a great company at sale prices?
In the near-term,
» Read more about: Is Apple’s Dip The Perfect Buying Opportunity? »
Read MoreThe Daily
CNBC anchor Andrew Ross Sorkin ‘anxious’ about stock market crash: ‘Reliving 1929’
Wall Street may be heading toward a 1929-style stock market crash — as inflated share prices, speculative bubbles and eroding financial safeguards feel eerily similar to the eve of the Great Depression, according to a financial journalist.
Andrew Ross Sorkin, who co-hosts CNBC’s “Squawk Box” and founded the New York Times’ DealBook newsletter,